Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Director departure
|
|
TRxADE HEALTH, INC (TRXD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/04/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/25/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
8-K
| Quarterly results |
| 07/10/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/30/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...|
Docs:
|
"AGREEMENT AND PLAN OF MERGER by and among TRXADE HEALTH, INC., FOODS MERGER SUB, INC., and Superlatus Inc. Dated as of June 30, 2023",
"List of Subsidiaries - ALL 100% OWNED ● Trxade, Inc., a Florida corporation ● Integra Pharma Solutions, Inc. , a Florida corporation ● Community Specialty Pharmacy, LLC, a Florida corporation ● Alliance Pharma Solutions, LLC, a Florida corporation ● Bonum Health, Inc a Delaware corporation ● Bonum Health, LLC, a Delaware corporation ● MedCheks, LLC, a Delaware corporation ● SOSRx LLC, a Delaware limited liability company Shareholder Amount of shares of Trxade Health, Inc. Exchanged Suren Ajjarapu 85,000 Prashant Patel 81,666 Post-Closing Allocation of Shares and Membership Interests in the Operating Subsidiaries Suren Ajjarapu: 51% Prashant Patel: 49%",
"Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution" |
|
| 06/15/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 04/06/2023 |
8-K
| Other Events Interactive Data |
| 03/27/2023 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"TRxADE HEALTH, INC. Consolidated Balance Sheets December 31, December 31, 2022 2021 Assets Current Assets Cash $ 1,133,633 $ 3,122,578 Accounts receivable, net 728,964 978,973 Inventory 119,582 56,279 Prepaid assets 110,944 216,414 Total Current Assets 2,093,123 4,374,244 Property plant and equipment, net 65,214 98,751 Intangible assets and capitalized software, net 450,845 - Deposits 49,029 60,136 Operating lease right-of-use assets 1,051,815 1,233,033 Total Assets $ 3,710,026 $ 5,766,164 Liabilities and Shareholders’ Equity Current Liabilities Accounts payable 729,153 477,028 Accrued liabilities 290,013 270,437 Other current liabilities 67,517 - Contingent funding liabilities 108,036 - Current portion lease liabilities 196,872 178,561 Warrant liability 588,533 - Notes payable— related pa..." |
|
| 03/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits... |
| 01/23/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"recitals A. Seller owns all of the membership interest in the Company, and the Company owns 100% of the software application known as DelivMeds. B. Buyer desires to purchase from Seller and Seller desires to sell to Buyer 100% of the Seller’ s membership interest in the Company . agreement Now, therefore, in consideration of the foregoing and the mutual agreements and covenants set forth below, which are acknowledged by each Party to be fair and adequate consideration for its obligations and commitments hereunder, the Parties hereby agree as follows: 1. Definitions. Except as otherwise set forth therein, as used in the Agreement and the Exhibits, Schedules and deliveries pursuant to the Agreement, the following definitions shall apply. “Company Assets” means the assets used in the Business...",
"recitals A. Seller owns all of the membership interest in the Company. B. Buyer desires to purchase from Seller and Seller desires to sell to Buyer 100% of the Seller’ s membership interest in the Company . agreement Now, therefore, in consideration of the foregoing and the mutual agreements and covenants set forth below, which are acknowledged by each Party to be fair and adequate consideration for its obligations and commitments hereunder, the Parties hereby agree as follows: 1. Definitions. Except as otherwise set forth therein, as used in the Agreement and the Exhibits, Schedules and deliveries pursuant to the Agreement, the following definitions shall apply. “Company Assets” means the assets used in the Business. “Action” means any action, complaint, petition, investigation, suit or o..." |
|
| 01/20/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"TRXADE HEALTH, INC. THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT is entered into on January 17, 2023, and effective as of September 1, 2022 , by and between TRxADE HEALTH, INC., a Delaware corporation , and Suren Ajjarapu, an individual . WHEREAS, effective on April 14, 2020, the Parties entered into an Executive Employment Agreement 1 , which was amended on May 5, 2020, by the entry into the First Amendment to Executive Employment Agreement 2 and on August 29, 2022 and effective as of September 1, 2022, by the entry into a Second Amendment to Employment Agreement 3 ; and WHEREAS, the Parties desire to amend the Agreement on the terms set forth below. NOW, THEREFORE, in consideration of the premises and the mutual covenants, agree...",
"TRXADE, INC. SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT is entered into on January 17, 2023, and effective as of September 1, 2022 , by and between TRxADE, INC., a Florida corporation , and Prashant Patel, an individual . WHEREAS, effective on May 24, 2013, the Parties entered into an Executive Employment Agreement 1 which was amended on August 29, 2022 to be effective September 2, 2022 by the entry into a First Amendment to Executive Employment Agreement 2 ; and WHEREAS, the Parties desire to amend the Agreement on the terms set forth below. NOW, THEREFORE, in consideration of the premises and the mutual covenants, agreements, and considerations herein contained, and other good and valuable consideration, which consideration ...",
"TRXADE HEALTH, INC. SECOND AMENDMENT TO OFFER LETTER THIS SECOND AMENDMENT TO OFFER LETTER is entered into on January 17, 2023, and effective as of September 1, 2022 , by and between TRxADE HEALTH, INC., a Delaware corporation , and Janet Huffman, an individual . WHEREAS, effective on February 3, 2022, the Parties entered into an Offer Letter 1 which was amended by the First Amendment to Offer Letter dated August 29, 2022, and effective as of September 1, 2022 2 ; and WHEREAS, the Parties desire to amend the Agreement on the terms set forth below. NOW, THEREFORE, in consideration of the premises and the mutual covenants, agreements, and considerations herein contained, and other good and valuable consideration, which consideration the parties hereby acknowledge and confirm the receipt and ..." |
|
| 01/05/2023 |
8-K
| Resignation/termination of a director |
| 12/21/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 12/16/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/01/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 11/07/2022 |
8-K
| Investor presentation|
Docs:
|
"TRxADE HEALTH, INC. Consolidated Balance Sheets September 30, December 31, 2022 2021 Current Assets Cash $ 321,715 $ 3,122,578 Accounts receivable, net 850,306 978,973 Inventory 75,950 56,279 Prepaid assets 249,785 216,414 Other receivable 875,250 - Total Current Assets 2,373,006 4,374,244 Property plant and equipment, net 68,036 98,751 Intangible assets and capitalized software, net 1,099,002 - Deposits 49,031 60,136 Operating lease right-of-use assets 1,100,186 1,233,033 Total Assets $ 4,689,261 $ 5,766,164 Current Liabilities Accounts payable 744,412 477,028 Accrued liabilities 312,077 270,437 Other current liabilities 105,926 - Contingent funding liabilities 542,143 - Current portion lease liabilities 190,127 178,561 Notes payable— related party 166,667 - Total Current liabilities 2,06..." |
|
| 10/19/2022 |
8-K
| Quarterly results |
| 10/14/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 10/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"PLACEMENT AGENCY AGREEMENT",
"FORM OF PRE-FUNDED WARRANT",
"FORM OF WARRANT",
"LEGAL OPINION",
"FORM OF SECURITIES PURCHASE AGREEMENT",
"TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering LUTZ, FL / ACCESSWIRE / October 4, 2022 / TRxADE HEALTH, INC. , a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $1.8 million of its common stock in a registered direct offering and warrants to purchase common stock in a concurrent private placement. The combined effective purchase price for one share of common stock and associated warrants will be $1.15." |
|
| 10/03/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"TR x ADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors TAMPA, FL – – TRxADE HEALTH, INC. , a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., announced today the appointment of Mr. Jeff Newell to the Company’ s Board of Directors. Prior to his appointment to the Board of Directors, Mr. Newell served on the Company’ s Advisory Board. Mr. Newell will serve as a strategic resource to TRxADE as it continues to develop its trade relationships in the industry. “We are thrilled to move industry expert, Mr. Newell from our Advisory board to our Board of Directors, and look forward to working w..." |
|
| 09/27/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 09/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"PURCHASE AND SALE OF COMMON STOCK Section 2.1 PURCHASE NOTICES . Upon the terms and conditions set forth herein , the Company shall have the right, but not the obligation, to require the Investor, by its delivery to the Investor of a Purchase Notice from time to time, to purchase Purchase Notice Shares provided that the amount of Purchase Notice Shares shall not exceed the Purchase Notice Limit or the Beneficial Ownership Limitation set forth in Section 7.2, . The Company may not deliver a subsequent Purchase Notice until the Closing of an active Purchase Notice, except if waived by the Investor in writing. Section 2.2 MECHANICS . PURCHASE NOTICE . At any time and from time to time during the Commitment Period, except as provided in this Agreement, the Company may deliver a Purchase Notice...",
"FIRST AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT This First Amendment to Common Stock Purchase Agreement , dated September 12, 2022 and effective as of September 7, 2022 , amends that certain Common Stock Purchase Agreement dated September 7, 2022 , by and between TRxADE HEALTH Inc., a Delaware corporation , and White Lion Capital LLC, a Nevada limited liability company , each a “ Party ” and collectively the “ Parties ”. Certain capitalized terms used below but not otherwise defined shall have the meanings given to such terms in the Purchase Agreement. WHEREAS, subsequent to entering into the Purchase Agreement, the Parties determined that certain changes and corrections were needed to be made to the Purchase Agreement to better reflect the intentions of the Parties; and WHEREAS, as a r...",
"SECOND AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT This Second Amendment to Common Stock Purchase Agreement , dated September 12, 2022 and effective as of September 7, 2022 , amends that certain Common Stock Purchase Agreement dated September 7, 2022, by and between TRxADE HEALTH Inc., a Delaware corporation , and White Lion Capital LLC, a Nevada limited liability company , as amended by the First Amendment to Common Stock Purchase Agreement dated September 12, 2022 and effective September 7, 2022 . Each of the Company and the Investor are referred to herein a “ Party ” and collectively the “ Parties ”. Certain capitalized terms used below but not otherwise defined shall have the meanings given to such terms in the Purchase Agreement. WHEREAS, subsequent to entering into the First Amendme..." |
|
| 09/01/2022 |
8-K
| Resignation/termination of a director|
Docs:
|
"TRXADE HEALTH, INC. SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT is entered into on August 29, 2022, and effective as of September 1, 2022 , by and between TRxADE HEALTH, INC., a Delaware corporation , and Suren Ajjarapu, an individual . WHEREAS, effective on April 14, 2020, the Parties entered into an Executive Employment Agreement 1 , which was amended on May 5, 2020, by the entry into the First Amendment to Executive Employment Agreement 2 ; and WHEREAS, the Parties desire to amend the Agreement on the terms set forth below. NOW, THEREFORE, in consideration of the premises and the mutual covenants, agreements, and considerations herein contained, and other good and valuable consideration, which consideration the parties hereb...",
"TRXADE, INC. FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT is entered into on August 29, 2022, and effective as of September 1, 2022 , by and between TRxADE, INC., a Florida corporation , and Prashant Patel, an individual . WHEREAS, effective on May 24, 2013, the Parties entered into an Executive Employment Agreement 1 ; and WHEREAS, the Parties desire to amend the Agreement on the terms set forth below. NOW, THEREFORE, in consideration of the premises and the mutual covenants, agreements, and considerations herein contained, and other good and valuable consideration, which consideration the parties hereby acknowledge and confirm the receipt and sufficiency thereof, the parties hereto agree as follows: 1. Amendment to Agreement . E...",
"TRXADE HEALTH, INC. FIRST AMENDMENT TO OFFER LETTER THIS FIRST AMENDMENT TO OFFER LETTER is entered into on August 29, 2022, and effective as of September 1, 2022 , by and between TRxADE HEALTH, INC., a Delaware corporation , and Janet Huffman, an individual . WHEREAS, effective on February 3, 2022, the Parties entered into an Offer Letter 1 ; and WHEREAS, the Parties desire to amend the Agreement on the terms set forth below. NOW, THEREFORE, in consideration of the premises and the mutual covenants, agreements, and considerations herein contained, and other good and valuable consideration, which consideration the parties hereby acknowledge and confirm the receipt and sufficiency thereof, the parties hereto agree as follows: 1. Amendment to Agreement . Effective as of the Effective Date, a...",
"NOTICE OF RESTRICTED STOCK GRANT",
"NOTICE OF RESTRICTED STOCK GRANT" |
|
| 08/01/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 07/26/2022 |
8-K/A
| Investor presentation |
| 07/25/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
8-K
| Quarterly results |
| 05/27/2022 |
8-K
| Quarterly results |
| 05/09/2022 |
8-K
| Quarterly results |
|
|
|